Shi Y, Liu H, Vanderburg G, Samuel S J, Ismail-Beigi F, Jung C Y
Department of Biophysical Sciences, State University of New York, New York, USA.
J Biol Chem. 1995 Sep 15;270(37):21772-8. doi: 10.1074/jbc.270.37.21772.
Brief (1-2 h) exposure of Clone 9 cells to inhibitors of oxidative phosphorylation such as azide is known to markedly increase glucose uptake. Clone 9 cells express GLUT1 but not GLUT2, -3, and -4, and the azide effect was not accompanied by any increase in cellular or plasma membrane GLUT1 level. To identify the molecular event underlying this apparent increase in GLUT1 intrinsic activity, we studied the acute effects of azide on the substrate binding activity of GLUT1 in Clone 9 cells by measuring glucose-sensitive cytochalasin B binding. The glucose-displaceable, cytochalasin B binding activity was barely detectable in membranes isolated from Clone 9 cells under control conditions but was readily detectable after a 60-min incubation of cells in the presence of 5 mM azide showing a 3-fold increase in binding capacity with no change in binding affinity. Furthermore, the cytochalasin B binding activity of purified human erythrocyte GLUT1 reconstituted in liposomes was significantly reduced in the presence of cytosol derived from azide-treated Clone 9 cells but not in the presence of cytosol from control cells; this effect was heat-labile and abolished by the presence of the peptide corresponding to the GLUT1 COOH-terminal sequence. These results suggest that a cytosolic protein in Clone 9 cells binds to GLUT1 at its COOH-terminal domain and inhibits its substrate binding and that azide-induced metabolic alteration releases GLUT1 from this inhibitory interaction. Studying the binding of cytosolic proteins derived from 35S-labeled Clone 9 cells to glutathione S-transferase fusion protein containing glucose transporter COOH-terminal sequences, we identified 28- and 70-kDa proteins that bind specifically to the cytoplasmic domain of GLUT1 and GLUT4 in vitro. We also found a 32P-labeled, 85-kDa protein that binds to GLUT4 but not to GLUT1 and only in cytosol derived from azide-treated cells. The roles, if any, of these glucose transporter-binding proteins in the azide-sensitive modulation of GLUT1 substrate binding activity in Clone 9 cells are yet to be determined.
已知将克隆9细胞短暂(1 - 2小时)暴露于氧化磷酸化抑制剂如叠氮化物中,可显著增加葡萄糖摄取。克隆9细胞表达GLUT1,但不表达GLUT2、-3和-4,且叠氮化物的作用并未伴随细胞或质膜GLUT1水平的任何增加。为了确定GLUT1内在活性这种明显增加背后的分子事件,我们通过测量葡萄糖敏感的细胞松弛素B结合,研究了叠氮化物对克隆9细胞中GLUT1底物结合活性的急性影响。在对照条件下,从克隆9细胞分离的膜中几乎检测不到葡萄糖可置换的细胞松弛素B结合活性,但在5 mM叠氮化物存在下将细胞孵育60分钟后,该活性易于检测到,显示结合能力增加了3倍,而结合亲和力没有变化。此外,在脂质体中重组的纯化人红细胞GLUT1的细胞松弛素B结合活性,在存在来自叠氮化物处理的克隆9细胞的胞质溶胶时显著降低,但在存在对照细胞的胞质溶胶时没有降低;这种效应是热不稳定的,并且在存在与GLUT1羧基末端序列对应的肽时被消除。这些结果表明,克隆9细胞中的一种胞质蛋白在其羧基末端结构域与GLUT1结合并抑制其底物结合,并且叠氮化物诱导的代谢改变使GLUT1从这种抑制性相互作用中释放出来。通过研究来自35S标记的克隆9细胞的胞质蛋白与含有葡萄糖转运蛋白羧基末端序列的谷胱甘肽S - 转移酶融合蛋白的结合,我们鉴定出在体外特异性结合GLUT1和GLUT4胞质结构域的28 kDa和70 kDa蛋白。我们还发现一种32P标记且分子量为85 kDa的蛋白,它仅在来自叠氮化物处理细胞的胞质溶胶中与GLUT4结合,而不与GLUT1结合。这些葡萄糖转运蛋白结合蛋白在克隆9细胞中对GLUT1底物结合活性的叠氮化物敏感调节中(如果有)所起的作用尚待确定。